JamesStevenEconomouMDPhD
General Surgery • Los Angeles, CASurgical Oncology (Other than Breast)
Professor, Surgery, UCLA School of Medicine
Are you Dr. Economou?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 120 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
200 Medical Plaza
120
Los Angeles, CA 90095Phone+1 310-794-1646Fax+1 310-825-2644
Summary
- Dr. James Economou, MD is a general surgeon in Los Angeles, California. He is currently licensed to practice medicine in California and Maryland. He is affiliated with Ronald Reagan UCLA Medical Center and is a Professor at UCLA School of Medicine.
Education & Training
University of California (San Francisco)Residency, Surgery, 1983 - 1986
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Urology, 1982 - 1983- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Surgery, 1980 - 1982
Johns Hopkins University School of MedicineClass of 1980
Certifications & Licensure
CA State Medical License 1982 - 2025
MD State Medical License 1980 - 1990- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Vaccine Therapy in Treating Patients With Liver Cancer Start of enrollment: 1999 Jul 01
- Vaccine Therapy in Treating Patients With Liver Cancer Start of enrollment: 2001 Jan 01
- Vaccine Therapy in Treating Patients With Stage IV or Recurrent Malignant Melanoma Start of enrollment: 2002 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 353 citationsIL-4 down-regulates IL-1 and TNF gene expression in human monocytes.Richard Essner, K Rhoades, William H. McBride, Donald L. Morton, James S. Economou
Journal of Immunology. 1989-06-01 - 95 citationsIonizing Radiation Affects Human MART-1 Melanoma Antigen Processing and Presentation by Dendritic CellsYu-Pei Liao, Chun-Chieh Wang, Lisa H. Butterfield, James S. Economou, Antoni Ribas
Journal of Immunology. 2004-08-15 - 3145 citationsTechnical details of intraoperative lymphatic mapping for early stage melanoma.Donald L. Morton, D. R. Wen, Jan H. Wong, James S. Economou, Leslie A. Cagle
Archives of Surgery. 1992-04-01
Press Mentions
UC Davis Health Surgery Chair to Lead Prestigious OrganizationApril 22nd, 2021- IconOVir Bio Announces Formation of Scientific Advisory BoardApril 20th, 2021
- Resiliency of a Perpetual Optimist: Neurosurgeon Dr. Linda LiauMarch 2nd, 2021
- Join now to see all
Grant Support
- PET Imaging Of MART Tcr-Engineered CD8 T Cell Immunotherapy In ManNational Cancer Institute2007–2011
- UCLA Clinical Scientist Training In Cancer Gene MedicineNational Cancer Institute2003–2007
- Dendritic Cell-Based Genetic Immunotherapy For MelanomaNational Cancer Institute2003–2007
- A Phase I Trial Testing Immunization With Dendritic Cells Pulsed With Four AFNational Center For Research Resources2005–2006
- UCLA Cancer Gene Medicine Training ProgramNational Cancer Institute2002–2006
- A Phase I Trial Testing MART-1 Genetic Immunization In Malignant MelanomaNational Center For Research Resources2005
- Phase I Trial Testing MART-1 Genetic Immunization In MNational Center For Research Resources2004
- Phase I Trial Testing Immunization With Dendritic CellNational Center For Research Resources2004
- Genetic Immunotherapy For Hepatocellular CancerNational Cancer Institute2001–2004
- Dendritic Cell Based Genetic Immunotherapy For MelanomaNational Cancer Institute1999–2002
- Clinical Scientist Training In Cancer Gene MedicineNational Cancer Institute1997–2002
- UCLA Gene Medicine Training ProgramNational Cancer Institute1997–2001
- Genetic Immunization Of Hepatocellular CancerNational Cancer Institute1998–2000
- Gene Therapy Of MelanomaNational Cancer Institute1995–1998
- Core--Vector Core LaboratoryNational Cancer Institute1995–1998
- Gene Therapy For CancerNational Cancer Institute1992–1998
- Phase I Trial Testing Genetically-Engineered Interleukin-7 MelanomaNational Center For Research Resources1996–1997
- Treatment Of Patients With Metastatic Melanoma And Renal Cell CancerNational Center For Research Resources1995
- Therapeutic Regulation Of TNF In IL-2 ImmunotherapyNational Cancer Institute1989–1993
- Regulation Of Macrophage Function By Interleukin-2National Cancer Institute1988–1990
Professional Memberships
- Member
- Member
